APPB — Applied Biosciences Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Applied Biosciences, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2015 March 31st | R2016 March 31st | 2017 March 31st | 2018 March 31st | 2019 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0 | 0 | 0.213 | 0.061 | 0.047 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | 0 | 0.006 | 0.012 | 0.163 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0 | 0 | 0.258 | 0.227 | 0.354 |
Net Property, Plant And Equipment | — | — | — | 0.004 | 0.452 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 0 | 0 | 1.68 | 0.705 | 3.65 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.013 | 0.008 | 0.032 | 0.036 | 0.374 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Liabilities | 0.013 | 0.008 | 0.033 | 0.027 | 1.52 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.013 | -0.008 | 1.64 | 0.678 | 2.13 |
Total Liabilities & Shareholders' Equity | 0 | 0 | 1.68 | 0.705 | 3.65 |
Total Common Shares Outstanding |